Building the Foundation for Next-Gen Biologics R&D
Alison Waterfield October 12, 2026
Advancing NGS-Based Workflows in Biopharma Development
Alison Waterfield October 2, 2026
RNA Therapeutics at Scale: Why Data Strategy Now Defines Success
Fiona Siebrits October 1, 2026
A Blueprint for GMP-Compliant Generative AI
Valentina Armiento September 21, 2026
Nanobody Discovery with NGS: From Dominant Clones to Repertoire-Level Insight
Craig Blyth September 18, 2026
From NGS Data to Scalable Antibody and Nanobody Development Workflows
How Translational Research Data Analysis Empowers Interdisciplinary Teams in Precision Medicine
Fiona Siebrits September 17, 2026
Making NGS Work for Analytical Development and QC
Justyna Lisowska August 25, 2026
Navigating Data Challenges in RNA Therapeutics: From Complexity to Clarity
Ming Wang August 3, 2026
核酸医薬品の創薬における課題はAIだけでは解決できない？
Justyna Lisowska, Ming Wang July 14, 2026
AI Agents: From Automation to Augmented Intelligence
Justyna Lisowska July 9, 2026
TIDES 2026より - 核酸医薬はウェットラボとドライラボが統合した「ビーチ型」の創薬へ
Ming Wang July 7, 2026
Adventitious Viral Detection in Biologics Manufacturing
Alison Waterfield July 7, 2026
Implementing NGS‑Based Assays in GxP Environments
Valentina Armiento July 7, 2026
GxP環境におけるNGSを用いた製品特性評価とバイオセーフティー試験の実現
Valentina Armiento July 1, 2026
NGSを活用した品質管理 - バイオ医薬品業界の新たなスタンダード
Arielle Mann June 16, 2026
GMP環境下の製造におけるNGS：リスク低減とリターンの最大化
Christoph Bredack June 15, 2026
Industry Perspectives on Preparing Validation-Ready NGS Workflows
Alison Waterfield May 17, 2026
実践的NGS - 欧州薬局方基準への対応
March 30, 2026
Genedata’s Unparalleled Partner Symposium, 2026 Edition
March 12, 2026
Digital Transformation in Biopharma Data Management
Raed Hmadi March 2, 2026
Automation in Biopharma: Cell Line & Process Development
Raed Hmadi February 26, 2026
Streamlining CGT Data for TCR Engineering
Raed Hmadi February 25, 2026
The Real Benefits (and Remaining Barriers) to AI in Biopharma
Mark Brewer, PhD, Ada Yee, PhD February 19, 2026
NGS Data Analysis Automation for R&D & QC
Raed Hmadi February 6, 2026
Unlocking Label-Free Live Cell Imaging with AI
Stephan Steigele February 2, 2026
Unlocking HT-MS with a Digital Ecosystem
Raed Hmadi January 19, 2026
GMPにおけるNGSアッセイバリデーション - 細胞・遺伝子治療になぜ不可欠なのか
Ludwig Macko, Valentina Armiento January 19, 2026
Driving Precision Medicine at Scale with Genedata
Justyna Lisowska December 19, 2025
How Is Automation Transforming Biomarker Discovery?
Justyna Lisowska November 25, 2025
Do The Math - ラボオートメーションにおけるROI
Jana Hersch November 14, 2025
How Can Data Translation Challenges in Biopharma–CRO Partnerships Be Overcome?
November 6, 2025
Accelerating High-Content Imaging Analysis with Automation
November 4, 2025
自動かつスケーラブルなMSデータ解析によるバイオ医薬品の開発可能性向上
October 14, 2025
MSデータ解析によるバイオ医薬品開発の変革
Industry Experiences in Bringing NGS-Based Workflows In-House
Alison Waterfield September 29, 2025
NGSとMAMによるCHO細胞株構築の最適化
Valentina Armiento September 11, 2025
Advancing CNS Therapeutics with Proteomics
Ada Yee, Benjamin Thomas September 11, 2025
Automating Oligonucleotide Drug Development
Arielle Mann August 25, 2025
Integrated Workflows for Antibody Development
Ada Yee August 25, 2025
